VIM and breast carcinoma: Fei et al. [92] demonstrated that by using the antimicrobial peptide merecidin to act on the cytoplasm of tumor cells in nude mice, increasing the expression of miR-770-5p can negatively regulate vimentin, thereby delaying the metastasis and proliferation of breast cancer cells.